Skip to main content

Table 2 Estimated LSMeans EQ-5D utility scores and EQ-5D VAS scores over 3 months by age group

From: Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above

Day 50–59 y N = 142 60–64 y N = 59 65–69 y N = 67 70–79 y N = 182 ≥ 80 y N = 63 All N = 513
  LSMean SE LSMean SE LSMean SE LSMean SE LSMean SE LSMean SE
EQ-5D utility scores
0 0.768 0.024 0.704 0.037 0.758 0.034 0.725 0.021 0.733 0.036 0.740 0.012
15 0.829 0.022 0.786 0.034 0.779 0.032 0.778 0.019 0.707 0.033 0.785 0.012
30 0.898 0.017 0.880 0.026 0.864 0.024 0.845 0.015 0.782 0.026 0.859 0.009
60 0.954 0.012 0.923 0.019 0.936 0.017 0.913 0.011 0.864 0.019 0.922 0.006
90 0.959 0.010 0.963 0.016 0.949 0.016 0.942 0.009 0.871 0.016 0.942 0.006
EQ-5D VAS scores
0 61.0 2.1 58.7 3.1 59.3 2.9 61.0 1.8 58.3 3.1 60.2 1.1
15 70.7 1.9 65.7 3.0 64.9 2.7 62.8 1.7 59.7 2.8 65.2 1.0
30 76.5 2.0 73.2 3.0 72.5 2.9 69.0 1.7 69.3 3.0 72.1 1.0
60 85.8 1.8 80.7 2.8 84.1 2.6 80.1 1.6 77.0 2.7 81.9 0.9
90 88.9 1.7 85.5 2.7 87.2 2.5 86.1 1.5 81.2 2.6 86.4 0.9
  1. LS least square, HZ herpes zoster, EQ-5D EuroQoL five-dimension scale, VAS visual analog scale, N total number in each age group, SE standard error, y years old